{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "The Optimal Prophylactic Method for Venous Thromboembolism After Gastrectomy in Korean Patients (PROTECTOR) randomized clinical trial"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "randomized clinical trial was conducted between August 1, 2011, and March 31, 2015"
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients with histologically confirmed gastric adenocarcinoma presenting to a single center (Seoul St Mary\u2019s Hospital in Seoul, South Korea) were enrolled"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Patients were randomized to either an intermittent pneumatic compression (IPC)\u2013only group or an IPC+low-molecular-weight (LMW) heparin sodium group"
      },
      "Objective": {
        "score": 1,
        "evidence": "To evaluate the incidence of postgastrectomy VTE in Korean patients with gastric adenocarcinoma, and to identify the complications and evaluate the efficacy and safety of VTE prevention methods"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Venous thromboembolism incidence was the primary outcome"
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Patients were randomized"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "Of the 682 patients enrolled and randomized"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Among the 666 patients included in the analysis, the overall incidence of VTE was 2.1%"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The incidence of VTE was statistically significantly higher in the IPC-only group compared with the IPC+LMW heparin group (3.6%; 95% CI, 2.05%-6.14% vs 0.6%; 95% CI, 0.17%-2.18%; P =\u2009.008)"
      },
      "Harms": {
        "score": 1,
        "evidence": "The overall incidence of bleeding complications was 5.1%"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "ClinicalTrials.gov Identifier: NCT01448746"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 20,
    "max_score": 25
  },
  "model": "gpt-4o"
}